Carvedilol (Carvedilol)



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 53.8%
Hypertension 15.4%
Cardiac Disorder 7.7%
Type 2 Diabetes Mellitus 7.7%
Pain 4.6%
Abdominal Discomfort 1.5%
Anticoagulant Therapy 1.5%
Anxiety 1.5%
Blood Pressure Abnormal 1.5%
Cardiac Failure 1.5%
Congestive Cardiomyopathy 1.5%
Haemorrhoids 1.5%
Toxicity To Various Agents 16.0%
Nausea 8.0%
Presyncope 8.0%
Atrial Fibrillation 4.0%
Bronchostenosis 4.0%
Cardiac Failure 4.0%
Diabetes Mellitus 4.0%
Dysstasia 4.0%
Electrocardiogram Qt Prolonged 4.0%
Fungal Skin Infection 4.0%
Hypertension 4.0%
Hypoglycaemia 4.0%
Mental Status Changes 4.0%
Orthostatic Hypotension 4.0%
Psoriatic Arthropathy 4.0%
Respiratory Tract Infection 4.0%
Sinus Arrest 4.0%
Sinus Bradycardia 4.0%
Somnolence 4.0%
Syncope 4.0%
Secondary
Product Used For Unknown Indication 49.2%
Pneumonia 4.9%
Pneumonitis 4.9%
Type 2 Diabetes Mellitus 4.9%
Angina Unstable 3.3%
Anticoagulant Therapy 3.3%
Antiplatelet Therapy 3.3%
Cardiomegaly 3.3%
Essential Hypertension 3.3%
Hypertension 3.3%
Polyuria 3.3%
Bronchitis 1.6%
Cardiac Failure 1.6%
Chronic Myeloid Leukaemia 1.6%
Coronary Artery Disease 1.6%
Diabetes Mellitus 1.6%
Gastrooesophageal Reflux Disease 1.6%
Heart Rate Abnormal 1.6%
Neoplasm Malignant 1.6%
Exposure Via Ingestion 15.0%
Tendonitis 15.0%
Completed Suicide 10.0%
Renal Failure Acute 10.0%
Anaphylactic Reaction 5.0%
Infection 5.0%
Lactose Intolerance 5.0%
Pustular Psoriasis 5.0%
Pyrexia 5.0%
Sepsis 5.0%
Somnolence 5.0%
Toxicity To Various Agents 5.0%
Urine Output Increased 5.0%
Vision Blurred 5.0%
Concomitant
Product Used For Unknown Indication 24.2%
Plasma Cell Myeloma 15.4%
Nephrogenic Anaemia 8.7%
Prostate Cancer 5.4%
Prostate Cancer Metastatic 5.4%
Rheumatoid Arthritis 4.7%
Type 2 Diabetes Mellitus 4.7%
Hypertension 4.0%
Cardiac Failure 3.4%
Chronic Myeloid Leukaemia 3.4%
Gait Disturbance 3.4%
Drug Use For Unknown Indication 2.7%
Multiple Sclerosis 2.7%
Coronary Artery Disease 2.0%
Multiple Myeloma 2.0%
Prophylaxis 2.0%
Status Epilepticus 2.0%
Actinic Keratosis 1.3%
Acute Lymphocytic Leukaemia 1.3%
Diabetic Nephropathy 1.3%
Vomiting 8.6%
Pancreatitis 6.9%
Unresponsive To Stimuli 6.9%
Weight Decreased 6.9%
White Blood Cell Count Decreased 6.9%
Hypertension 5.2%
Myocardial Infarction 5.2%
Pain In Extremity 5.2%
Rectal Haemorrhage 5.2%
Renal Failure Acute 5.2%
Rhabdomyolysis 5.2%
Urinary Tract Infection 5.2%
Dyspnoea 3.4%
Fatigue 3.4%
Gout 3.4%
Malaise 3.4%
Nausea 3.4%
Oedema 3.4%
Pain 3.4%
Pancytopenia 3.4%